by MM360 Staff | Feb 19, 2026 | Myeloma News
Source: Pharmacy Times articles Post Content Read More
by MM360 Staff | Feb 19, 2026 | Uncategorized
Source: CURE articles Post Content Read More
by Andrea Lobo | Feb 18, 2026 | Myeloma News
Adding Elenagen, Curelab Oncology’s experimental anticancer medication, to gemcitabine chemotherapy may help women with treatment-resistant ovarian cancer live significantly longer. Those are the results of a small clinical trial, conducted at a single center in...
by MM360 Staff | Feb 18, 2026 | Uncategorized
Source: CURE articles Post Content Read More
by Andrea Lobo | Feb 17, 2026 | Myeloma News
A new, ultrasensitive blood test checks for cancer cells remaining in the body after multiple myeloma treatment using blood samples instead of more invasive bone marrow biopsies, helping doctors assess relapse risk and monitor treatment response. Quest Diagnostics...
